{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:09:28Z","timestamp":1790802568462,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,8,11]],"date-time":"2004-08-11T00:00:00Z","timestamp":1092182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00198-004-1712-4","type":"journal-article","created":{"date-parts":[[2004,8,10]],"date-time":"2004-08-10T17:24:33Z","timestamp":1092158673000},"page":"501-509","source":"Crossref","is-referenced-by-count":52,"title":["Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients"],"prefix":"10.1007","volume":"16","author":[{"given":"Senji","family":"Okuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Kitatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,8,11]]},"reference":[{"key":"CR1","first-page":"57","volume":"30","author":"Piraino","year":"1988","unstructured":"Piraino B, Chen T, Cooperstein L, Segre G, Puschett J (1988) Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30:57\u201362","journal-title":"Clin Nephrol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","volume":"11","author":"Delmas","year":"2000","unstructured":"Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11: S2\u2013S17","journal-title":"Osteoporos Int"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s007740170002","volume":"19","author":"Nishizawa","year":"2001","unstructured":"Nishizawa Y, Nakamura T, Ohata H, Kushida K, Gorai I, Shiraki M et al. (2001) Guidelines on the use of biochemical markers of bone turnover in osteoporosis. J Bone Miner Metab 19:338\u2013344","journal-title":"J Bone Miner Metab"},{"key":"CR4","first-page":"64","volume":"27","author":"Furumitsu","year":"2000","unstructured":"Furumitsu Y, Inaba M, Yukioka K, Yukioka M, Kumeda Y, Azuma Y et al. (2000) Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis. J Rheumatol 27:64\u201370","journal-title":"J Rheumatol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/ajkd.2002.33400","volume":"39","author":"Inaba","year":"2002","unstructured":"Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y et al. (2002) Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 39:1261\u20131269","journal-title":"Am J Kidney Dis"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","volume":"55","author":"Ure\u00f1a","year":"1999","unstructured":"Ure\u00f1a P, De Vemejoul MC (1999) Circulating biochemical markers of bone remodelling in uremic patients. Kidney Int 55:2141\u20132156","journal-title":"Kidney Int"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/clinchem\/47.8.1410","volume":"47","author":"Okabe","year":"2001","unstructured":"Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H et al. (2001) Clinical evaluation of the Elecsys \u03b2-CrossLaps serum assay, a new assay that measures serum concentrations of bone-derived degradation products of type I collagen C-telopeptides. Clin Chem 47:1410\u20131414","journal-title":"Clin Chem"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1074\/jbc.272.15.9755","volume":"272","author":"Fledelius","year":"1997","unstructured":"Fledelius C, Johnsen AH, Cloos PA, Bonde M, Quist P (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a \u03b2-isomerized Asp-Gly sequence within the C-terminal telopeptide (\u03b11) region. J Biol Chem 272:9755\u20139763","journal-title":"J Biol Chem"},{"key":"CR9","first-page":"864","volume":"80","author":"Bonde","year":"1995","unstructured":"Bonde M, Qvist P, Fledelius C, Riis BJ, Chiristiansen C (1995) Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 80:864\u2013868","journal-title":"J Clin Endocrinol Metab"},{"key":"CR10","first-page":"4157","volume":"85","author":"Kumeda","year":"2000","unstructured":"Kumeda Y, Inaba M, Tahara H, Kurioka Y, Isikawa T, Morii H et al. (2000) Persistent increase in bone turnover in Graves\u2019 patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85:4157\u20134161","journal-title":"J Clin Endocrinol Metab"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s001980050180","volume":"9","author":"Inaba","year":"1999","unstructured":"Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T et al. (1999) Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 9:525\u2013531","journal-title":"Osteoporos Int"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0026-0495(99)90227-5","volume":"48","author":"Inaba","year":"1999","unstructured":"Inaba M, Terada M, Nishizawa Y, Shioi A, Ishimura E, Otani S et al. (1999) Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. Metabolism 48:904\u2013909","journal-title":"Metabolism"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","volume":"44","author":"Lepage","year":"1998","unstructured":"Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C et al. (1998) A non-(1\u201394) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805\u2013809","journal-title":"Clin Chem"},{"key":"CR14","unstructured":"Arnaud CD, Pun KK (1992) Metabolism and assay of parathyroid hormone. In: Coe FL, Favus MJ (eds) (1992) Disorders of bone and mineral metabolism. Raven Press, New York, pp\u00a0107\u2013122"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","volume":"41","author":"Gomes","year":"1995","unstructured":"Gomes B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff YD et al. (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41:1560\u20131566","journal-title":"Clin Chem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0009-8981(99)00251-X","volume":"294","author":"Takahashi","year":"2000","unstructured":"Takahashi M, Kushida K, Nagano A, Inoue T (2000) Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clin Chim Acta 294:67\u201376","journal-title":"Clin Chim Acta"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/clinchem\/41.10.1439","volume":"41","author":"Rosenquist","year":"1995","unstructured":"Rosenquist C, Qvist P, Bjarnason N, Christiansen C (1995) Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 41:1439\u20131445","journal-title":"Clin Chem"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0009-8981(95)06012-8","volume":"235","author":"Niwa","year":"1995","unstructured":"Niwa T, Shiobara K, Hamada T, Miyazaki T, Tsukushi S, Uema K et al. (1995) Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients. Clin Chim Acta 235:33\u201340","journal-title":"Clin Chim Acta"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1515\/CCLM.2000.166","volume":"38","author":"Pagani","year":"2000","unstructured":"Pagani F, Bonetti G, Stefini F, Panteghini M (2000) Evaluation of a fully automated assay to measure C-telopeptide of type I collagen in serum. Clin Chem Lab Med 38:1111\u20131113","journal-title":"Clin Chem Lab Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S8756-3282(96)00246-3","volume":"19","author":"Yamaguchi","year":"1996","unstructured":"Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S (1996) Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 19:549\u2013555","journal-title":"Bone"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0272-6386(96)90461-8","volume":"28","author":"Stein","year":"1996","unstructured":"Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ (1996) Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 28:515\u2013522","journal-title":"Am J Kidney Dis"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1007\/BF03194371","volume":"7","author":"Miki","year":"1997","unstructured":"Miki T, Morita A, Nakatsuka K, Tabata T, Inoue T, Nishizawa Y et al. (1997) Changes in bone mineral density in patients on hemodialysis due to chronic glomerulonephritis. Osteoporos Int 7:S193\u2013S196","journal-title":"Osteoporos Int"},{"key":"CR23","first-page":"S38","volume":"25","author":"Lindergard","year":"1994","unstructured":"Lindergard B, Cederholm B (1994) Long-time follow-up (10\u201322 years) of bone mineral density in patients on uninterrupted hemodialysis for more than 10 years. Bone Miner 25:S38","journal-title":"Bone Miner"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","volume":"66","author":"Rosen","year":"2000","unstructured":"Rosen HM, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL et al. (2000) Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66:100\u2013103","journal-title":"Calcif Tissue Int"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000045928","volume":"87","author":"Malyszko","year":"2001","unstructured":"Malyszko J, Wolczynski S, Zbroch E, Brzosko S, Malyszko J, Mysliwiec M (2001) Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients. Nephron 87:283\u2013285","journal-title":"Nephron"},{"key":"CR26","first-page":"S1","volume":"42","author":"National","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guideline for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1\u2013S202","journal-title":"Am J Kidney Dis"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/jbmr.5650100614","volume":"10","author":"Ure\u00f1a","year":"1995","unstructured":"Ure\u00f1a P, Ferreira A, Kung VT, Morieux C, Simon P, Ang KS et al. (1995) Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res 10:932\u2013939","journal-title":"J Bone Miner Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1359\/jbmr.1999.14.9.1614","volume":"14","author":"Garnero","year":"1999","unstructured":"Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD (1999) Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res 14:1614\u20131621","journal-title":"J Bone Miner Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","volume":"13","author":"Ross","year":"1998","unstructured":"Ross PD, Knowlton W (1998) Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 13:297\u2013302","journal-title":"J Bone Miner Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s002239900135","volume":"59","author":"Dresner-Pollak","year":"1996","unstructured":"Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL (1996) Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59:328\u2013333","journal-title":"Calcif Tissue Int"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","volume":"13","author":"Parfitt","year":"1998","unstructured":"Parfitt AM (1998) A structural approach to renal bone disease. J Bone Miner Res 13:1213\u20131220","journal-title":"J Bone Miner Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1681\/ASN.V971225","volume":"9","author":"Schober","year":"1998","unstructured":"Schober HC, Han ZH, Foldes AJ, Shih MS, Rao DS, Balena R et al. (1998) Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol 9:1225\u20131233","journal-title":"J Am Soc Nephrol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1712-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-004-1712-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1712-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T04:51:58Z","timestamp":1682743918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-004-1712-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1712"],"URL":"https:\/\/doi.org\/10.1007\/s00198-004-1712-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,11]]}}}